Intech Investment Management LLC Makes New Investment in Masimo Co. (NASDAQ:MASI)

Intech Investment Management LLC purchased a new stake in shares of Masimo Co. (NASDAQ:MASI) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 10,278 shares of the medical equipment provider’s stock, valued at approximately $1,294,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Hsbc Holdings PLC increased its stake in Masimo by 382.5% during the 2nd quarter. Hsbc Holdings PLC now owns 27,609 shares of the medical equipment provider’s stock valued at $3,510,000 after buying an additional 21,887 shares during the period. Vanguard Personalized Indexing Management LLC increased its stake in shares of Masimo by 3.2% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 5,374 shares of the medical equipment provider’s stock valued at $677,000 after acquiring an additional 166 shares during the period. Sofinnova Investments Inc. raised its holdings in Masimo by 0.8% during the second quarter. Sofinnova Investments Inc. now owns 20,161 shares of the medical equipment provider’s stock worth $2,539,000 after purchasing an additional 161 shares in the last quarter. Edgestream Partners L.P. acquired a new stake in Masimo in the second quarter worth approximately $645,000. Finally, Dimensional Fund Advisors LP increased its position in shares of Masimo by 45.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 525,594 shares of the medical equipment provider’s stock valued at $66,201,000 after purchasing an additional 165,257 shares during the period. 85.96% of the stock is currently owned by institutional investors.

Masimo Stock Up 0.9 %

Shares of Masimo stock opened at $126.18 on Wednesday. The company has a quick ratio of 1.15, a current ratio of 2.09 and a debt-to-equity ratio of 0.55. Masimo Co. has a 12-month low of $75.22 and a 12-month high of $153.93. The firm has a market capitalization of $6.71 billion, a PE ratio of 85.84 and a beta of 0.98. The stock’s fifty day moving average is $115.66 and its 200-day moving average is $124.85.

Masimo (NASDAQ:MASI) last posted its quarterly earnings data on Tuesday, August 6th. The medical equipment provider reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.77 by $0.09. The company had revenue of $496.30 million during the quarter, compared to analyst estimates of $493.92 million. Masimo had a net margin of 3.94% and a return on equity of 14.07%. The business’s quarterly revenue was up 9.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.62 earnings per share. Equities analysts anticipate that Masimo Co. will post 3.87 earnings per share for the current year.

Analysts Set New Price Targets

MASI has been the subject of several research analyst reports. Piper Sandler upped their price objective on Masimo from $160.00 to $165.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a report on Friday, September 20th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Masimo currently has an average rating of “Moderate Buy” and a consensus target price of $144.67.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.